Dr Lalchandani Labs Ltd (BSE: 541299) is a New Delhi, Delhi-based company in the Medical Diagnostic Centres industry. With a market capitalisation of ₹6 Cr, it ranks #5,334 by market cap among the 6,189 Indian listed companies on FinBizNet, and #17 of 18 in Medical Diagnostic Centres. At ₹6.96 (as of 26 Oct 2026), the share price is 70.6% below its 52-week high of ₹23.69 and 19.8% above its 52-week low of ₹5.81. The share price is down 69.1% over one year and down 12.7% over three months.
| Current Price | ₹6.96 |
|---|---|
| Market Cap | ₹6 Cr |
| BSE Code | 541299 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Services > Medical Diagnostic Centres |
| P/E Ratio | 99.4 |
| Return on Equity | 4.28% |
| Return on Assets | -1.86% |
| 52-Week Range | ₹5.81 – ₹23.69 |
| 1-Year Price Change | -69.1% |
| 3-Month Price Change | -12.7% |
| Beta (1Y) | -0.56 |
| Headquarters | New Delhi, Delhi |
| Website | www.lalchandanipathlab.com |
Dr Lalchandani Labs Limited provides diagnostic and related healthcare tests and services in India. The company offers doctor consultation, pathology, radiology, hospital lab management, corporate health checkup, and blood bank services, as well as X-ray, TMT, ultrasound, 2D-echo, and medical fitness examinations. It also offers its products online. The company serves individual patients, hospitals and other healthcare providers, and corporate customers. Dr Lalchandani Labs Limited was founded in 1986 and is based in New Delhi, India.
1. B2B-This segment provides a range of diagnostic and related healthcare tests and services for use in core testing and patient diagnosis, as well as the prevention, monitoring, and treatment of disease and other health conditions. 2. B2C-This segment provides a range of diagnostic and related healthcare tests and services for use in core testing and patient diagnosis, as well as the prevention, monitoring, and treatment of disease and other health conditions. 3. Healthcare and Diagonis Services-This segment provides diagnostic and related healthcare tests and services. It offers patients and healthcare providers a range of diagnostic and related healthcare tests and services for use in core testing and patient diagnosis, as well as the prevention, monitoring, and treatment of disease and
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Vijaya Diagnostic Centre Limited | ₹14,311 Cr | 82.8 | 19.70% | ₹231 Cr | +40.7% |
| Metropolis Healthcare Limited | ₹10,849 Cr | 56.9 | 13.37% | ₹450 Cr | +7.3% |
| Throcare Technologies Ltd | ₹7,357 Cr | 45.3 | 28.74% | ₹240 Cr | +8.9% |
| Dr. Agarwal'S Eye Hospital Ltd | ₹2,434 Cr | 34.3 | 25.22% | — | +20.0% |
| Krsnaa Diagnostics Ltd | ₹1,617 Cr | 16.1 | 10.89% | ₹236 Cr | -38.8% |
| SURAKSHA DIAGNOSTIC LIMITED | ₹1,559 Cr | 48.4 | 13.84% | ₹88 Cr | -0.3% |
| Gaudium IVF and Women Health Limited | ₹670 Cr | 23.5 | 16.08% | ₹19 Cr | — |
| Chandan Healthcare Limited | ₹535 Cr | 20.3 | — | ₹81 Cr | — |
| Dr Lalchandani Labs Ltd | ₹6 Cr | 99.4 | 4.28% | — | -69.1% |
Listed by market capitalisation. Ratios are shown for context only.
Dr Lalchandani Labs Ltd is trading at ₹6.96, with a market capitalisation of ₹6 Cr.
Dr Lalchandani Labs Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Medical Diagnostic Centres).
Dr Lalchandani Labs Ltd has a P/E of 99.4 and a return on equity of 4.28%.
Dr Lalchandani Labs Ltd is listed on the BSE under the scrip code 541299.
Dr Lalchandani Labs Ltd's share price is down 69.1% over one year and down 12.7% over three months. Its 52-week range is ₹5.81 to ₹23.69.
Data as of 26 Oct 2026. Descriptive market data only — not investment advice.